Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Carbon dioxide (CO2) as an alternative contrast agent in percutaneous transluminal angioplasty procedures for chronic limb-threatening ischemia patients with chronic kidney disease

Heart Science Journal · Vol. 5 No. 4 (2024) · hlm. 92–97

DOI
10.21776/ub.hsj.2024.005.04.16
ISSN
2721-9984, 2721-9976
Terbit
2024-10-28
Penerbit
Universitas Brawijaya
Bahasa
en

Abstrak

Background: Chronic limb-threatening ischemia (CLTI) is a very morbid illness that significantly reduces quality of life. The severity of this disease may necessitate revascularization or amputation.Arteriography is frequently performed for the planning of revascularization. Patients with compromised kidney function need alternative contrast agents.CO2 may be utilized in lower extremity vascular diagnostics and intervention, especially in patients at risk for contrast-induced nephropathy (CIN).Case Illustration: An 80-year-old female with bilateral leg pain and leg swelling had an ulcer on her toe for 2 weeks. She had a history of intermittent claudication for 1 year, hypertension for 5 years, kidney stones for 2 years, and chronic kidney disease for 1 year. She underwent an ECG, laboratory, USG, DUS, and CT-angiography examination. From her laboratory result, her initial creatinine was 5.02 mg/dL (eGFR 8 mL/m/1.73 m2). After good hydration, it became 1.28 mg/dL (eGFR 39 mL/m/1.73 m2). After a CT-angiography procedure, her creatinine level was increased (3.7 mg/dL; eGFR 10.9 mL/m/1.73 m2). She was diagnosed with CLTI Rutherford V Fontain 3 left lower extremity. She suggested doing an angioplasty procedure with a safer contrast agent. An angioplasty procedure was done at RSSA Malang with CO2 contrast. After the procedure, her leg pain improved, and her creatinine didn’t elevate.Conclusion: CO2 angiography might be used as a safe alternative contrast medium in patients with CLTI, which benefits the preservation of renal function and prevents limb amputations.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 250 tautan kepenulisan bersama · 14 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Brawijaya
  • RSUD Prof. Dr. Saiful Anwar Malang
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Mohammad Saifur RohmanUniversity of Brawijaya15
Cholid Tri TjahjonoUniversity of Brawijaya14
Sasmojo WiditoUniversity of Brawijaya11
Djanggan SargowoUniversity of Brawijaya10
Ardian RizalUniversity of Brawijaya9
Anna Fuji RahimahUniversity of Brawijaya8
Heny MartiniUniversity of Brawijaya6
Budi SatrijoUniversity of Brawijaya6
Indra PrasetyaUniversity of Brawijaya6
Setyasih AnjarwaniUniversity of Brawijaya5
Seprian WidasmaraUniversity of Brawijaya3
Adhika Prastya WikanandaUniversity of Brawijaya3
Sawitri SatwikajatiUniversity of Brawijaya3
Putri Annisa KamilaUniversity of Brawijaya2
Irma KameliaUniversity of Brawijaya2
Dyah Ayu IkeningrumRSUD Prof. Dr. Saiful Anwar Malang2
Oktafin Srywati PamunaUniversity of Brawijaya2
Zainal FathurohimUniversity of Brawijaya2
Nikhen NoverikeUniversity of Brawijaya2
Titin Andri WihastutiUniversity of Brawijaya2
Imam Mi'raj SuprayogaUniversity of Brawijaya2
Dea Arie KurniawanUniversity of Brawijaya2
Malombassi Dharmawan Hadiwidjojo HutomoUniversity of Brawijaya2
Ryan RamadhanUniversity of Brawijaya1
Ardian RizalUniversity of Brawijaya1
Veny KurniawatiUniversity of Brawijaya1
Aris Munandar Zulkifli IsmailUniversity of Brawijaya1
Dedy IrawanUniversity of Brawijaya1
Monika SitioUniversity of Brawijaya1
Muhammad Rizki FadlanUniversity of Brawijaya1
Liemena Harold AdrianRSUD Prof. Dr. Saiful Anwar Malang1
Ayu Asri Devi AdityawatiUniversity of Brawijaya1
Anna Fuji RahimahAfiliasi tidak diketahui1
Imelda KrisnasariUniversity of Brawijaya1
Fahmy RusnantaUniversity of Brawijaya1
Yudi Putra ApridityaUniversity of Brawijaya1
Ratna PancasariUniversity of Brawijaya1
Valerinna Yogibuana Swastika PutriUniversity of Brawijaya1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://heartscience.ub.ac.id/index.php/heartscience/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Carbon dioxide (CO2) as an alternative contrast agent in percutaneous transluminal angioplasty procedures for chronic limb-threatening ischemia patients with chronic kidney disease</dc:title>
	<dc:creator xml:lang="en">Vori, Ira</dc:creator>
	<dc:creator xml:lang="en">Kurnianingsih, Novi</dc:creator>
	<dc:subject xml:lang="en">Peripheral artery disease</dc:subject>
	<dc:subject xml:lang="en">Chronic limb threatening ischemia</dc:subject>
	<dc:subject xml:lang="en">Chronic limb ischemia</dc:subject>
	<dc:subject xml:lang="en">Chronic kidney disease</dc:subject>
	<dc:subject xml:lang="en">Contrast induced nephropathy</dc:subject>
	<dc:subject xml:lang="en">CO2 angiography</dc:subject>
	<dc:description xml:lang="en">Background: Chronic limb-threatening ischemia (CLTI) is a very morbid illness that significantly reduces quality of life. The severity of this disease may necessitate revascularization or amputation.Arteriography is frequently performed for the planning of revascularization. Patients with compromised kidney function need alternative contrast agents.CO2 may be utilized in lower extremity vascular diagnostics and intervention, especially in patients at risk for contrast-induced nephropathy (CIN).Case Illustration: An 80-year-old female with bilateral leg pain and leg swelling had an ulcer on her toe for 2 weeks. She had a history of intermittent claudication for 1 year, hypertension for 5 years, kidney stones for 2 years, and chronic kidney disease for 1 year. She underwent an ECG, laboratory, USG, DUS, and CT-angiography examination. From her laboratory result, her initial creatinine was 5.02 mg/dL (eGFR 8 mL/m/1.73 m2). After good hydration, it became 1.28 mg/dL (eGFR 39 mL/m/1.73 m2). After a CT-angiography procedure, her creatinine level was increased (3.7 mg/dL; eGFR 10.9 mL/m/1.73 m2). She was diagnosed with CLTI Rutherford V Fontain 3 left lower extremity. She suggested doing an angioplasty procedure with a safer contrast agent. An angioplasty procedure was done at RSSA Malang with CO2 contrast. After the procedure, her leg pain improved, and her creatinine didn’t elevate.Conclusion: CO2 angiography might be used as a safe alternative contrast medium in patients with CLTI, which benefits the preservation of renal function and prevents limb amputations.</dc:description>
	<dc:publisher xml:lang="en">Universitas Brawijaya</dc:publisher>
	<dc:date>2024-10-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://heartscience.ub.ac.id/index.php/heartscience/article/view/13097</dc:identifier>
	<dc:identifier>10.21776/ub.hsj.2024.005.04.16</dc:identifier>
	<dc:source xml:lang="en">Heart Science Journal; Vol. 5 No. 4 (2024): The Current Perspective About Cardiometabolic Disease; 92-97</dc:source>
	<dc:source>2721-9984</dc:source>
	<dc:source>2721-9976</dc:source>
	<dc:source>10.21776/ub.hsj.2024.005.04</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://heartscience.ub.ac.id/index.php/heartscience/article/view/13097/446</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2024 Ira Vori, Novi Kurnianingsih</dc:rights>
</oai_dc:dc>